National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 655529

History of Changes from the VAERS Wayback Machine

First Appeared on 1/14/2017

655529
VAERS Form:
Age:
Gender:Female
Location:Foreign
Vaccinated:2011-03-14
Onset:0000-00-00
Submitted:2016-09-27
Entered:2016-09-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hypermobility syndrome, Increased tendency to bruise, Injection site bruising, Injection site pain, Lymphadenopathy, Menstrual disorder, Muscle disorder, Myalgia, Nausea, Paraesthesia, Pyrexia, Rash, Sensory disturbance, Skin striae, Syncope, Vomiting, Fibromyalgia, Injection site swelling, Haemorrhage

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature measurement (unknown date): pyrexia
CDC 'Split Type': WAES1609IRL012492

Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number IE-1577272925-2016009610) on 26-SEP-2016. This case was received from the agency on 21-SEP-2016 under the reference number IR-HPRA-2016-028844. Initial report was received by the agency on 07-SEP-2016, from a member of the public (patient''s mother) which concerns a 12 year old female patient who experienced injection site swelling, headache, pyrexia, nausea, lymphadenopathy, muscular disorder, skin striae, rash, hypermobility syndrome, syncope, injection site pain, injection site bruising and fibromyalgia following vaccination with GARDASIL. Concomitant medications: none. Medical history/concurrent conditions: none. The patient was vaccinated with 3 doses of GARDASIL (dose 1 on 13-SEP-2010 (batch/lot no. NM11420), dose 2 on 17-NOV-2010 (batch no. NM46680) and dose 3 on 14-MAR-2011 (batch no. NM3113). The patient collapsed after dose 1 and was sent home from school. She also became quite ill after each subsequent dose. She experienced pain, swelling and bruising at injection site, headaches, fever, nausea, swollen glands, muscle weakness, tingling/abnormal sensations in arms and legs, vomiting, joint pain, aching muscles, chronic fatigue, chills, bleeding and bruising easily, issues with menstrual cycle, stretch marks, skin rash and hypermobility. The patient has been seen by a number of consultants for different symptoms, has been hospitalized on a number of occasions and is currently waiting to be seen by more specialists. At present she has been diagnosed with fibromyalgia and has told by a rheumatologist and a number of physiotherapists that she is hypermobile. The reporter indicated that no diagnosis has been made to cover all of her symptoms. At the time of reporting the patient''s symptoms were persisting.


Changed on 9/14/2017

655529 Before After
VAERS Form:(blank) 1
Age:
Gender:Female
Location:Foreign
Vaccinated:2011-03-14
Onset:0000-00-00
Submitted:2016-09-27
Entered:2016-09-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 3 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hypermobility syndrome, Increased tendency to bruise, Injection site bruising, Injection site pain, Lymphadenopathy, Menstrual disorder, Muscle disorder, Myalgia, Nausea, Paraesthesia, Pyrexia, Rash, Sensory disturbance, Skin striae, Syncope, Vomiting, Fibromyalgia, Injection site swelling, Haemorrhage

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature measurement (unknown date): pyrexia
CDC 'Split Type': WAES1609IRL012492

Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number IE-1577272925-2016009610) on 26-SEP-2016. This case was received from the agency on 21-SEP-2016 under the reference number IR-HPRA-2016-028844. Initial report was received by the agency on 07-SEP-2016, from a member of the public (patient''s mother) which concerns a 12 year old female patient who experienced injection site swelling, headache, pyrexia, nausea, lymphadenopathy, muscular disorder, skin striae, rash, hypermobility syndrome, syncope, injection site pain, injection site bruising and fibromyalgia following vaccination with GARDASIL. Concomitant medications: none. Medical history/concurrent conditions: none. The patient was vaccinated with 3 doses of GARDASIL (dose 1 on 13-SEP-2010 (batch/lot no. NM11420), dose 2 on 17-NOV-2010 (batch no. NM46680) and dose 3 on 14-MAR-2011 (batch no. NM3113). The patient collapsed after dose 1 and was sent home from school. She also became quite ill after each subsequent dose. She experienced pain, swelling and bruising at injection site, headaches, fever, nausea, swollen glands, muscle weakness, tingling/abnormal sensations in arms and legs, vomiting, joint pain, aching muscles, chronic fatigue, chills, bleeding and bruising easily, issues with menstrual cycle, stretch marks, skin rash and hypermobility. The patient has been seen by a number of consultants for different symptoms, has been hospitalized on a number of occasions and is currently waiting to be seen by more specialists. At present she has been diagnosed with fibromyalgia and has told by a rheumatologist and a number of physiotherapists that she is hypermobile. The reporter indicated that no diagnosis has been made to cover all of her symptoms. At the time of reporting the patient''s symptoms were persisting.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=655529&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166